New research co-authored by Yale SOM’s Paul Goldsmith-Pinkham shows that a proactive approach, in which jurisdictions respond to infections in neighboring areas, can dramatically lower spread in the early stages of an epidemic.
COVID-19 vaccine acceptance is significantly higher in low- and middle-income countries than wealthy ones. Prioritizing those countries for vaccine distribution could help save more lives and keep variants at bay.
Nationally, infection rates are close to their low point and many Americans are resuming their usual activities, but the more transmissible Delta variant is spreading and vaccinations are still low in some areas. We asked Yale SOM's Dr. Howard Forman where things stand now.
COVID-19 restrictions on restaurants, bars, gyms and salons were among the most controversial and the last to be lifted. A new study looks at whether closures, capacity restrictions, and other limits on these businesses actually lowered the death rate.
A Yale study conducted in the early days of the COVID-19 pandemic found that feeling like part of a team reduced reported stress and burnout—an insight with implications for how any kind of organization can weather a crisis.
A team of researchers, including Yale SOM’s Jason Abaluck and Mushfiq Mobarak, tested multiple methods for encouraging use of masks in Bangladesh and identified a group of simple interventions that tripled usage.
A study co-authored by Yale SOM’s James Choi tested a variety of text messages to prompt people to get flu vaccines, offering one potential tool to encourage those who aren’t rushing to get a COVID shot.
A new Yale study says that a partnership with the Dollar General retail chain, which is being considered by the CDC, could bring vaccination sites substantially closer to low-income, Black, and Hispanic households in many parts of the United States.
What will change the minds of those reluctant to get the COVID-19 vaccine? Yale SOM’s Vineet Kumar and two Yale doctors used the tools of consumer marketing to survey hesitant healthcare workers and analyze their responses.
Josh Geballe ’02, Connecticut’s chief operating officer, explains the state’s controversial decision to switch to age-based eligibility for COVID vaccines—and says it likely saved lives.
There is another epidemic we cannot lose sight of: the opioid epidemic, which has become only more acute in the United States and elsewhere amidst the disruptions and stress caused by COVID-19.